About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
+64 (0) 27 578 9663
Investor Relations Manager
+64 (0) 27 807 8073
Please find attached to this news release the following additional documents:
• Results in Brief
• Annual Report 2019
• Investor Presentation 2019
• Annual Review 2019
• NZX Results Announcement
• NZX Distribution Notice
The 2019 Annual Report is also available online at https://annualreport.fphcare.com/.
Constant Currency Information
Constant currency information included within this news release is non-conforming financial information, as defined by the NZ Financial Markets Authority, and has been provided to assist users of financial information to better understand and track the company’s comparative financial performance without the impacts of spot foreign currency fluctuations and hedging results and has been prepared on a consistent basis each year. A constant currency analysis is included on page 36 of the company’s Annual Report 2019 and the company’s constant currency income statement framework can be found on the company’s website at www.fphcare.com/ccis.
Full Year Results Conference Call
Fisher & Paykel Healthcare will host a conference call today to review the results and to discuss the outlook for the 2020 financial year. The conference call is scheduled to begin at 10:00am NZST, 8:00am AEST (6:00pm USEDT) and will be broadcast simultaneously over the internet.
To listen to the webcast, access the company’s website at www.fphcare.com/investor. Please allow extra time prior to the webcast to visit the site and download the streaming media software if required. An online archive of the event will be available approximately two hours after the webcast and will remain on the site for two weeks.
To attend the conference call, participants will need to dial in to one of the numbers below 5 to 10 minutes prior to the scheduled call time and identify yourself to the operator. When prompted, please quote the conference code of: 7242707.
New Zealand Toll Free - 0800 423 970
US/Canada Toll Free - 800 458 4121
Australia Toll Free - 1800 573 793
Hong Kong Toll Free - 800 961 105
United Kingdom Toll Free - 0800 358 6377
International - +64 9 913 3622
Fisher & Paykel Healthcare Reports Record Full Year Result, Achieves Revenue Milestone of NZ$1 Billion
Find clinical evidence and practice guidelines for delivering nasal high flow (aka HFNC) therapy.
Providing Optimal Humidity for intubated patients
Featuring under nose NIV masks (F&P Visairo) and full face NIV masks - (F&P Nivairo), with vented and non-vented options to suit your hospital NIV mask needs.
Establish effective spontaneous breathing or assist ventilation of the lungs
Respiratory support that replaces spontaneous breathing
Noninvasive respiratory support that provides a continuous distending pressure
Noninvasive respiratory support that delivers high flows of blended air and oxygen
Designed to work in harmony with the way patients naturally breathe while they sleep
F&P SleepStyle - designed to strike the balance between comfort and effective treatment